Orio Therapeutics

Orio Therapeutics has developed technology modifying the therapeutic proteins that control localisation after injection, improving tissue repair at lower doses while reducing costs and side effects. In doing so, they allow the injected molecule to stay at the injection site, improving tissue regeneration and repair at lower doses while reducing costs and side effects.

Orio has prioritised their new technology for patients with myocardial infarction, assisting in the preservation of cardiac function and reducing fibrosis and cellular death following a heart attack. With this emergent technology capable of modifying any protein-based therapeutic, Orio has the potential to transform the field of regenerative medicine, drastically improving therapies that could change the lives of sufferers of fibrosis.

Year established: 2023
Lead Researcher & Co-Founder: Mikaël Martino
Website: oriotx.com